Last reviewed · How we verify
NCT06173388
Exercise Training for Cervicogenic Dysphagia
NA trial testing Structured exercise training program + The swallow resistance exercise program. in Dysphagia, Esophageal in 32 participants. Completed in 20 May 2023.
20 January 2023
Quick facts
| Lead sponsor | Umm Al-Qura University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 1 February 2022 |
| Primary completion | 20 January 2023 |
| Estimated completion | 20 May 2023 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- Structured exercise training program + The swallow resistance exercise program.
- Only the swallow resistance exercise program.
Conditions studied
- Dysphagia, Esophageal — all drugs for Dysphagia, Esophageal →
Sponsor
Umm Al-Qura University
Who can join
Adults 35 to 50, any sex, with Dysphagia, Esophageal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Cervicogenic dysphagia is a swallowing difficulty caused by cervical problems that negatively impact pulmonary health, and quality of life and may increase the risk of mortality. Study design: Randomized Controlled Study Purpose: The purpose was to explore the effect of a structured exercise training program composed of cervical stretching, strengthening and stabilizing exercises on the swallowing function, craniovertebral angle, and pulmonary function in patient with cervicogenic dysphagia. Methods: 32 patients (age 35-50 years) with cervicogenic dysphagia were randomly allocated into study group (n=17) and control group (n=15). The craniovertebral angle (CVA), the swallowing function (using the swallow-difficulty questionnaire "SDQ") and the pulmonary function (including the forced vital capacity "FVC" and forced expiratory volume in one second "FEV1") were evaluated pre-study and post-study. All participants received three sessions/week for 8-weeks. The study group received the structured exercise program, in addition to the swallow resistance exercise (SRE), while the control group received the swallow resistance exercise only.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06173388
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dysphagia, Esophageal
Currently open trials in the same condition.
- NCT06398405 — A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer · Phase 2 · recruiting
- NCT06196606 — Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction · NA · recruiting
- NCT05629325 — Buspirone for Weak or Absent Esophageal Peristalsis · Phase 4 · recruiting
- NCT04503785 — Esophageal Impedance and Manometry Measurements and Dysphagia Symptom Scoring · recruiting
Other Umm Al-Qura University trials
Trials by the same sponsor.
- NCT07322861 — Virtual Reality-Based vs Traditional Physiotherapy for Balance, Frailty, and Fall Prevention in Adults Aged 45 Years and · NA · not yet recruiting
- NCT06735963 — Evaluating the Impact of a Meta Quest 3 Gamified VR Rehabilitation Program in Knee Osteoarthritis · NA · not yet recruiting
- NCT07515417 — Effect of Magnesium Supplementation on Sleep Quality and Cognitive Function in Saudi Adults · NA · active not recruiting
- NCT06974435 — Interval Training and Electromagnetic Therapy on Cardiovascular Disease Risk in Diabetic Elderly · NA · completed
- NCT06974422 — Weight Off-loading Training, Cardiovascular Indices, Diabetes · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06173388 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Umm Al-Qura University
- Last refreshed: 25 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06173388.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing